About
Small Molecules, Biologics
Areas of Focus
Categories
Biologics & BiopharmaceuticalSmall Molecule PharmaceuticalNJ, NY, PA
Team (3)
Clinical Trials (20)
View allTotal Trials
20
As Lead Sponsor
17
As Collaborator
3
Total Enrollment
2,133
By Phase
EARLY_PHASE1: 1PHASE1/PHASE2: 4PHASE1: 8PHASE2: 6PHASE3: 1
By Status
COMPLETED: 8TERMINATED: 7RECRUITING: 2SUSPENDED: 1ACTIVE_NOT_RECRUITING: 1UNKNOWN: 1
Clinical Trials Pipeline20 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT05817890Lead Sponsor
Absorption, Metabolism, and Excretion of CYC065 in Healthy Male Subjects
EARLY_PHASE1Completed
8 participants
Started: Mar 3, 2023 · Completed: May 22, 2024
NCT05358379Lead Sponsor
A Study to Investigate CYC140, in Subjects With Advanced Solid Tumors and Lymphoma
PHASE1/PHASE2Recruiting
330 participants
Started: Apr 14, 2022 · Completed: Nov 30, 2025
NCT05168904Lead Sponsor
A Study to Investigate Fadraciclib (CYC065), in Subjects With Leukemia or Myelodysplastic Syndrome (MDS)
PHASE1/PHASE2Suspended
210 participants
Started: Oct 22, 2021 · Completed: Dec 31, 2024
NCT04983810Lead Sponsor
A Study to Investigate Fadraciclib (CYC065), in Subjects With Advanced Solid Tumors and Lymphoma
PHASE1/PHASE2Recruiting
330 participants
Started: Jul 12, 2021 · Completed: Jun 30, 2025
NCT04017546Lead Sponsor
CYC065 CDK Inhibitor and Venetoclax Study in Relapsed/Refractory AML or MDS
PHASE1Completed
14 participants
Started: Aug 2, 2019 · Completed: Apr 5, 2023
Locations (1)
Headquarters
Berkeley Heights, NJ, United States
Map
Loading map...